
浏览全部资源
扫码关注微信
上海中医药大学,上海 201203
王莉新,博士,助理研究员,从事中西医结合抗肿瘤研究,E-mail:wlx831208@126.com
朱诗国,博士,研究员,从事中西医结合抗肿瘤研究, E-mail:jusco105@163.com
收稿日期:2018-10-08,
网络出版日期:2019-01-04,
纸质出版日期:2019-07-20
移动端阅览
王莉新, 吴文斌, 胥孜杭, 等. 黄芪甲苷通过诱导M1型巨噬细胞极化发挥抗肿瘤作用的机制[J]. 中国实验方剂学杂志, 2019,25(14):19-24.
Li-xin WANG, Wen-bin WU, Zi-hang XU, et al. Anti-tumor Effect of Astragaloside by Inducing M1 Macrophage Polarization[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(14): 19-24.
王莉新, 吴文斌, 胥孜杭, 等. 黄芪甲苷通过诱导M1型巨噬细胞极化发挥抗肿瘤作用的机制[J]. 中国实验方剂学杂志, 2019,25(14):19-24. DOI: 10.13422/j.cnki.syfjx.20190822.
Li-xin WANG, Wen-bin WU, Zi-hang XU, et al. Anti-tumor Effect of Astragaloside by Inducing M1 Macrophage Polarization[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(14): 19-24. DOI: 10.13422/j.cnki.syfjx.20190822.
目的:
2
探讨黄芪甲苷对巨噬细胞极化的影响及其可能的抗肿瘤免疫机制。
方法:
2
通过噻唑兰(methylthiazolyldiphenyl-tetrazolium bromide,MTT)比色法检测不同浓度黄芪甲苷作用不同时间,对巨噬细胞的细胞毒作用,以选取合适的黄芪甲苷作用浓度;将巨噬细胞与肿瘤细胞以1∶1进行共孵育,并用0.1 mg·L
-1
黄芪甲苷作用24 h,通过虫荧光素酶(luciferase,Luc)杀伤实验检测巨噬细胞对肿瘤细胞的杀伤效率;以0.1 mg·L
-1
黄芪甲苷作用巨噬细胞24 h,通过流式细胞术检测巨噬细胞CD16/32,CD206表达,通过实时荧光定量聚合酶链式反应(Real-time PCR)检测巨噬细胞诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS),精氨酸-1(Arginine-1,Arg-1)及细胞因子白细胞介素-1
β
(interleukin-1
β
,IL-1
β
),肿瘤坏死因子-
α
(tumor necrosis factor-
α
,TNF-
α
),白细胞介素-12(interleukin-12,IL-12),白细胞介素-10(interleukin-10,IL-10),转化生长因子-
β
(transforming growth factor-
β
,TGF-
β
)mRNA表达,通过蛋白免疫印迹法(Western blot)检测巨噬细胞信号传导及转录激活因子1(Signal transducers and activators of transcription 1
STAT1),磷酸化信号传导及转录激活因子1(phosphorylation signal transducers and activators of transcription 1
p-STAT1)表达。
结果:
2
当黄芪甲苷质量浓度为0.1 mg·L
-1
时,对巨噬细胞无细胞毒作用。与空白组比较,Luc杀伤实验结果显示黄芪甲苷可以显著促进巨噬细胞介导的肿瘤杀伤;Real-time PCR结果显示黄芪甲苷可以诱导巨噬细胞表面M1型巨噬细胞标志CD16/32表达增高,促进M1型巨噬细胞特异性指标iNOS mRNA表达,同时诱导M1型巨噬细胞相关细胞因子IL-1
β
,TNF-
α
,IL-12 mRNA表达增高;Western blot结果显示黄芪甲苷可以促进巨噬细胞STAT1发生磷酸化。
结论:
2
黄芪甲苷可以通过促进巨噬细胞内STAT1发生磷酸化,进而诱导巨噬细胞向M1型巨噬细胞发生极化,并启动巨噬细胞相关的抗肿瘤免疫应答。
Objective:
2
To investigate the effect of astragaloside on the macrophage polarization and the possible anti-tumor immunity mechanism of astragaloside.
Method:
2
The cytotoxic effect of different concentrations of astragaloside at different time points on macrophage was measured by methylthiazolyldiphenyl-tetrazolium bromide (MTT)
in order to choose the suitable concentration of astragaloside
macrophages were co-cultured with tumor cells at the ratio 1∶1
and the effect of astragaloside on macrophage-mediated lysis of tumor cells was performed by biophotonic cytotoxicity assay after the mixed cells were effected with 0.1 mg·L
-1
astragaloside for 24 h. Macrophages were dealt with 0.1 mg·L
-1
astragaloside for 24h
the expressions of CD16/32 and CD206 in macrophages were performed by flow cytometry
the mRNA expressions of macrophage inducible nitric oxide synthase (iNOS)
Arginine-1 (Arg-1)
interleukin-1
β
(IL-1
β
)
tumor necrosis factor-
α
(TNF-
α
)
interleukin-12 (IL-12)
interleukin-10 (IL-10) and transforming growth factor-
β
(TGF-
β
) were measured by Real-time PCR
the protein expressions of macrophage signal transducers and activators of transcription 1 (STAT1) and phosphorylation signal transducers and activators of transcription 1 (p-STAT1) were determined by Western blot.
Result:
2
Astragaloside had no effect on the viability of macrophages with 0.1 mg·L
-1
. Compared with control group
astragaloside obviously enhanced the macrophage-mediated lysis of tumor cells according to the biophotonic cytotoxicity assay
induced the M1 macrophage marker CD16/32 expression according to flow cytometry
increased the mRNA expressions of iNOS
IL-1
β
TNF-
α
and IL-12 according to the Real-time PCR
and promoted the phosphorylation of STAT1 in macrophages on the basis of Western blot.
Conclusion:
2
Astragaloside could induce M1 macrophage polarization by increasing the phosphorylation of STAT1
and initiate macrophage-related anti-tumor immunity response.
CHEN W , ZHENG R , Baade P D , et al . Cancer statistics in China, 2015 [J]. CA Cancer J Clin , 2016 , 66 ( 2 ): 115 - 132 .
Siegel R , Naishadham D , Jemal A . Cancer statistics, 2013 [J]. CA Cancer J Clin , 2013 , 63 ( 1 ): 11 - 30 .
Albini A , Magnani E , Noonan D M . The tumor microenvironment: biology of a complex cellular and tissue society [J]. Q J Nucl Med Mol Imaging , 2010 , 54 ( 3 ): 244 - 248 .
Schreiber R D , Old L J , Smyth M J . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion [J]. Science , 2011 , 331 ( 6024 ): 1565 - 1570 .
Kerkar S P , Restifo N P . Cellular constituents of immune escape within the tumor microenvironment [J]. Cancer Res , 2012 , 72 ( 13 ): 3125 - 3130 .
YUAN R , LI S , GENG H , et al . Reversing the polarization of tumor-associated macrophages inhibits tumor matastasis [J]. Int Immunopharmacol , 2017 , 49 : 30 - 37 .
LUO Y , WU J , ZHU X , et al . NK cell-dependent growth inhibition of Lewis lung cancer by Yu-Ping-Feng, an ancient Chinese herbal formula [J]. Med Inflamm , 2016 , doi: 10.1155/2016/3541283 http://doi.org/10.1155/2016/3541283 .
陈卓 , 于卫江 . 注射用黄芪多糖对非小细胞肺癌放疗的作用及对机体免疫的影响 [J]. 中国实验方剂学杂志 , 2013 , 19 ( 6 ): 309 - 313 .
刘苓霜 . 刘嘉湘辨治肺癌经验 [J]. 中医文献杂志 , 2006 , 24 ( 2 ): 38 - 40 .
刘嘉湘 , 陈树森 , 郁仁存 , 等 . 肺癌证治 [J]. 中医杂志 , 1986 , 27 ( 3 ): 4 - 7 .
桑国优 , 韦世秀 , 刘成军 . 黄芪抗肿瘤作用机制和临床应用研究进展 [J]. 时珍国医国药 , 2008 , 19 ( 12 ): 3032 - 3034 .
杨苏钰 , 唐德才 , 曹子丰 , 等 . 黄芪甲苷配伍姜黄素对人卵巢癌HO-8910原位移植瘤转移的抑瘤作用 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 6 ): 155 - 160 .
Sica A , Mantovani A . Macrophage plasticity and polarization: in vivo veritas [J]. J Clin Invest , 2012 , 122 ( 3 ): 787 - 795 .
Mosser D M , Edwards J P . Exploring the full spectrum of macrophage activation [J]. Nat Rev Immunol , 2008 , 8 ( 12 ): 958 - 969 .
Lewis C E , Pollard J W . Distinct role of macrophages in different tumor microenvironments [J]. Cancer Res , 2006 , 66 ( 2 ): 605 - 612 .
Mantovani A , Sozzani S , Locati M , et al . Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes [J]. Trends Immunol , 2002 , 23 ( 11 ): 549 - 555 .
Goerdt S , Orfanos C E . Other functions, other genes: alternative activation of antigen-presenting cells [J]. Immunity , 1999 , 10 ( 2 ): 137 - 142 .
Mantovani A , Allavena P . The interaction of anticancer therapies with tumor-associated macrophage [J]. J Exp Med , 2015 , 212 ( 4 ): 435 - 445 .
Mantovani A , Marchesi F , Malesci A , et al . Tumor-associated macrophages as treatment targets in oncology [J]. Nat Rev Clin Oncol , 2017 , 14 ( 7 ): 399 - 416 .
Biswas S K , Allavena P , Mantovani A . Tumor-associated macrophage: functional diversity, clinical significance, and open questions [J]. Semin Immunopathol , 2013 , 35 ( 5 ): 585 - 600 .
Hagemann T , Lawrence T , McNeish I , et al . Re-educating tumor-associated macrophages by targeting NF-kappaB [J]. J Exp Med , 2008 , 205 ( 6 ): 1261 - 1268 .
KE S , Ziemiecki A , Wilks A F , et al . Polypeptide signaling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins [J]. Nature , 1993 , 366 ( 6455 ): 580 - 583 .
Darnell J E J , Kerr I M , Stark G R . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins [J]. Science , 1994 , 264 ( 5164 ): 1415 - 1421 .
0
浏览量
18
下载量
17
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621